CAJ | 학술논문

评价肺心病急性加重期采用低分子肝素联合酚妥拉明治疗的的临床效果。方法：选取入住我院进行治疗的肺心病急性加重期患者200名，按照完全随机抽样的方法，随机分为2个组：对照组、实验组。对照组采用常规疗法，实验组在常规疗法基础上采用低分子肝素和酚妥拉明的联合疗法。观察并比较两组患者的治疗情况。结果：患者经过治疗后，实验组总有效率为88.00%，对照组总有效率为49.00%，实验组明显高于对照组，具有统计学意义(P<0.05)；实验组血液全血粘度、血浆粘度和红细胞聚集指数在治疗前后具有显著差异(P<0.05)且较对照组三项指标均具有显著性差异，具有统计学意义(P<0.05)。结论：在对肺心病急性加重期患者进行治疗的过程中，通过采用低分子肝素和酚妥拉明的联合治疗，效果显著，急性加重期患者疾病状况明显改善，可在临床上广泛应用。
평개폐심병급성가중기채용저분자간소연합분타랍명치료적적림상효과。방법：선취입주아원진행치료적폐심병급성가중기환자200명，안조완전수궤추양적방법，수궤분위2개조：대조조、실험조。대조조채용상규요법，실험조재상규요법기출상채용저분자간소화분타랍명적연합요법。관찰병비교량조환자적치료정황。결과：환자경과치료후，실험조총유효솔위88.00%，대조조총유효솔위49.00%，실험조명현고우대조조，구유통계학의의(P<0.05)；실험조혈액전혈점도、혈장점도화홍세포취집지수재치료전후구유현저차이(P<0.05)차교대조조삼항지표균구유현저성차이，구유통계학의의(P<0.05)。결론：재대폐심병급성가중기환자진행치료적과정중，통과채용저분자간소화분타랍명적연합치료，효과현저，급성가중기환자질병상황명현개선，가재림상상엄범응용。
To evaluated the low molecular heparin combine with phentolamine in treatment of acute exacerbation of pulmonary heart disease. Methods: 200 patients with acute exacerbation of pulmonary heart disease in our hospital were selected, and divided them into control group and experimental group by randomly. The control group was treated by routine treatment, and the experimental group was treated by low molecular heparin combine with phentolamine on the basis of routine treatment. To observed and compared the treatment of two groups’ patients. Results: The patients after treatment, the total efficiency of experimental group was 88%, the total efficiency of control group was 49%, the experimental group was significantly higher than control group, differences were statistical y significant(P<0.05); the blood viscosity of whole blood, plasma viscosity and erythrocyte aggregation index of experimental group before and after therapy had significant differences(P<0.05),and compared with the control group of three indicators, differences were statistical y significant(P<0.05). Conclusion: In the course of acute exacerbation of pulmonary heart disease patients treated by combination therapy using low molecular weight heparin and phentolamine, the effect is significant, in patients with acute exacerbation of disease status improved significantly, it’s worthy of being applied in clinic.